845
Participants
Start Date
September 12, 2025
Primary Completion Date
September 30, 2026
Study Completion Date
September 30, 2026
Combined metabolic activators
A total of 20g of CMA2 with strawberry aroma and colouring agent will be given. The IMP will be provided as a soluble powder packed as individual dosages in identical sachets. The powder should be dissolved in 200 ml preferably cold water before use. The powder can also be used on yoghurt or other food. The subjects will take two daily oral doses of the IMP, one dose just after breakfast and one dose just after dinner. Subjects who cannot tolerate (e.g., diarrhoea) taking full dose will be withdrawn from the study.
Collagen and maltodextrin
As placebo, a total of 20g of compound primarily containing collagen and maltodextrin will be administered. Placebo contains strawberry aroma flavouring and colouring agent.
NOT_YET_RECRUITING
Department of Neurology and Neuroscience, Faculty of Medicine, Alaaddin Keykubat University, Alanya
RECRUITING
Ataturk University, Faculty of Medicine, Department of Neurology, Erzurum, Turkey; Movement Disorders and Neuromodulation Center, Ataturk University, Erzurum
RECRUITING
Behavioural Neurology and Movement Disorders Unit, Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul
NOT_YET_RECRUITING
Department of Neurology, School of Medicine, Koc University, Istanbul
NOT_YET_RECRUITING
Haydarpaşa Numune Training and Research Hospital, University of Health Sciences Istanbul, Istanbul
NOT_YET_RECRUITING
Sancaktepe Şehit Prof. Dr. İlhan Varank Training and Research Hospital, University of Health Sciences Istanbul, Istanbul
RECRUITING
SB Haseki Training and Research Hospital, Istanbul, University of Health Sciences Istanbul, Istanbul
RECRUITING
Sultan Abdülhamid Han Training and Research Hospital, University of Health Sciences Istanbul, Istanbul
RECRUITING
Umraniye Training and Research Hospital, University of Health Sciences Istanbul, Istanbul
ScandiBio Therapeutics AB
INDUSTRY